SLC12A3 and Gordon syndrome: This is highlighted by loss-of-function NCC mutations underlying hypotensive Gitelman's syndrome or activation of NCC in hypertensive pseudohypoaldosteronism type II (PHAII or Gordon syndrome) (3, 4, 5).